Discovery of potent, highly selective and orally efficacious SMARCA2 degraders

被引：0
|
作者：
Leng, Lingying
Yang, Lin
Tu, Wenbin
Rej, Rohan
Allu, Srinivasa Rao
Huang, Liyue
Jiang, Wei
Wang, Yu
Stuckey, Jeanne
Sarkari, Farzad R.
Wang, Meilin
Wang, Lu
Wen, Bo
Sun, Duxin
Wang, Shaomeng
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4506
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4506
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of Potent, Highly Selective, and Efficacious SMARCA2 Degraders
    Li, Zhenwu
    Harikrishnan, Lalgudi S.
    Xu, Guozhang
    Samanta, Debangshu
    Clemente, Jose C.
    Leng, Lingying
    Tu, Wenbin
    Yang, Lin
    Huang, Liyue
    Wang, Mi
    Wang, Shaomeng
    Deng, Qiaolin
    Behshad, Elham
    Nagilla, Rakesh
    Orth, Peter
    Rice, Cory
    Strickland, Corey
    Mohammad, Helai P.
    Priestley, E. Scott
    Sui, Zhihua
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 68 (02) : 1134 - 1154
  • [2] Development of potent, highly selective and efficacious SMARCA2 degraders
    Yang, Lin
    Tu, Wenbin
    Huang, Liyue
    Leng, Lingying
    Jiang, Wei
    Wang, Meilin
    Wen, Bo
    Sun, Duxin
    Stuckey, Jeanne
    Wang, Shaomeng
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders
    Leng, Lingying
    Tu, Wenbin
    Yang, Lin
    Huang, Liyue
    Wang, Mi
    Meagher, Jennifer L.
    Chinnaswamy, Krishnapriya
    Allu, Srinivasa Rao
    Rej, Rohan Kalyan
    Tosovic, Jelena
    Harikrishnan, Lalgudi
    Li, Zhenwu
    Sui, Zhihua
    Stuckey, Jeanne A.
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1113 - 1133
  • [4] Discovery of orally bioavailable SMARCA2/4 dual degraders for treatment of acute myeloid leukemia
    Abbineni, Chandrasekhar
    Khare, Leena
    Kuila, Bilash
    Khaji, Abdul Rawoof
    Mahadeo, Dhaytadak Bhagwan
    Dukare, Sandeep Vitthal
    Kumar, Bhagya M. S.
    Gore, Suraj T.
    Ahuja, Vijay Kamal
    Dhudashiya, Amit A.
    Raghavendra, N. R.
    Gowda, Nagesh
    Charamanna, K. B.
    Aithal, Kiran B.
    Samiulla, D. S.
    Mukherjee, Subhendu
    Antony, Thomas
    Giri, Sanjeev
    Chelur, Shekar
    Nellore, Kavitha
    Daginakatte, Girish
    Ramachandra, Murali
    Samajdar, Susanta
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Orally bioavailable SMARCA2 degraders with exceptional selectivity and potency.
    Abbineni, Chandrasekhar
    Satyam, Leena Khare
    Kuila, Bilash
    Ettam, Ashok
    Rawoof, Khaji Abdul
    Sreevidya, M. R.
    Dukare, Sandeep Vitthal
    Gore, Suraj T.
    Nankar, Rakesh P.
    Ahuja, Vijay Kamal
    Charamanna, K. B.
    Goyal, Megha
    Aithal, Kiran
    Samiulla, D. S.
    Mukherjee, Subhendu
    Antony, Thomas
    Giri, Sanjeev
    Chelur, Shekar
    Nellore, Kavitha
    Daginakatte, Girish
    Ramachandra, Murali
    Samajdar, Susanta
    CANCER RESEARCH, 2021, 81 (13)
  • [6] Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human Cancers
    Yang, Lin
    Tu, Wenbin
    Leng, Lingying
    Huang, Liyue
    Jiang, Wei
    Wang, Mi
    Wang, Yu
    Meagher, Jennifer L.
    Chinnaswamy, Krishnapriya
    Stuckey, Jeanne A.
    Wang, Meilin
    Wen, Bo
    Sun, Duxin
    Harikrishnan, Lalgudi
    Strickland, Corey
    Rice, Cory
    Orth, Peter
    Sui, Zhihua
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 1155 - 1178
  • [7] Discovery of oral SMARCA2 degraders for the treatment of SMARCA4 mutant tumors
    Clemente, Jose C.
    Harikrishnan, Lal
    Knight, Steve
    Samanta, Debangshu
    Li, Zhenwu
    Nagilla, Rakesh
    Kendsersky, Nathan
    Joshi, Shreyas
    Orth, Peter
    Tudor, Matt
    Deng, Qiaolin
    Aguilar-Bonavides, Clemente
    Behshad, Elham
    Sui, Zhihua
    Strickland, Corey
    Jolivette, Larry J.
    Mohammad, Helai P.
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Selective and orally bioavailable SMARCA2 targeted degraders induce synthetic lethality in SMARCA4-deficient solid tumor
    Ito, Koichi
    Shvartsbart, Artem
    Rager, Joseph
    Agarwal, Anjana
    Hulse, Michael
    Vykuntam, Komali
    Wang, Min
    Kurian, Justin
    Cowart, Miles
    Cote, Joy
    Sivakumar, Monisha
    Carter, Jack
    Burtell, Jessica
    Grego, Alex
    Moore, Andrew
    Bhagwat, Neha
    Ruepp, Stefan
    Emme, Tom
    Lu, Liang
    Pitis, Philip
    Basch, Corey
    Bersch, Klare
    Mei, Song
    Leal, Raul
    Rose, John
    Roth, Danielle
    Cao, Ganfeng
    Vaddi, Kris
    Geeganage, Sandy
    Ruggeri, Bruce
    Combs, Andrew
    Scherle, Peggy
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Preclinical characterization of PRT7732: A highly potent, selective, and orally bioavailable targeted protein degrader of SMARCA2
    Shvartsbart, Artem
    Ito, Koichi
    Rager, Joseph
    Hulse, Michael
    Agarwal, Anjana
    Vykuntam, Komali
    Burtell, Jessica
    Wang, Min
    Kurian, Justin
    Cowart, Miles
    Cote, Joy
    Stahl, Nick
    Sivakumar, Monisha
    Reichelderfer, Anthony
    Carter, Jack
    Grego, Alexander
    Moore, Andrew
    Bhagwat, Neha
    Kuskovsky, Ross
    Ganesan, Shanthi
    Ruepp, Stefan
    Emm, Tom
    Pitis, Philip
    Basch, Corey
    Bersch, Klare
    Pan, Yongchun
    Mei, Song
    Leal, Raul
    Rose, John
    Roth, Dani
    Xu, Chaoyi
    Cao, Ganfeng
    Vaddi, Kris
    Lee, Sang Hyun
    Geeganage, Sandy
    Combs, Andrew
    Scherle, Peggy
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Identification of paralog selective degraders of SMARCA2 and SMARCA4 for treatment of various cancers
    Abbineni, Chandrasekhar
    Aithal, Kiran
    Khare, Leena
    Dukare, Sandeep, V
    Kuila, Bilash
    Goyal, Megha
    Rawoof, Khaji Abdul
    Mahadeo, Dhaytadak Bhagwan
    Kumar, Bhagya M. S.
    Premkumar, M.
    Sahu, Swetangini
    Gore, Suraj T.
    Krishna, Lavanya N.
    Charamanna, K. B.
    Gopinath, C. H.
    Samiulla, D. S.
    Mukherjee, Subhendu
    Antony, Thomas
    Gin, Sanjeev
    Chelur, Shekar
    Nellore, Kavitha
    Daginakatte, Girish
    Ramachandra, Murali
    Samajdar, Susanta
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345